Cardiology
Cardiovascular clinical trials are scientifically complex due to the multifaceted nature of heart disease. Patient variability, the need for diverse endpoints (mortality, function, quality of life), long-term follow-up requirements, and the challenge of finding reliable biomarkers all necessitate a team with deep scientific understanding, robust trial design skills, and meticulous data analysis capabilities.
We are a leading Contract Research Organization (CRO) with extensive experience in designing, managing, and executing successful clinical trials for a wide range of cardiovascular diseases. Our team of seasoned medical and clinical experts is passionate about propelling the development of life-saving therapies that improve patient outcomes.
How We Can Help
Our clinical research services have played a pivotal role in advancing therapies for a wide range of cardiovascular diseases. We have contributed to the development of cardiovascular medications and medical devices that have enhanced patient outcomes and improved cardiovascular health. Following are some of our key specialties:
- Hypertension: Expertise in developing and evaluating medications for long-term blood pressure control, including innovative therapies for resistant hypertension.
- Chronic Stable Angina Pectoris: Proven track record in designing and conducting trials for medications that improve exercise tolerance and quality of life in angina patients.
- Vasospastic Angina: Experience in researching and developing therapies specifically targeting vasospasms and reducing angina attacks.
- Edema due to Cardiac Failure: A focus on clinical trials for diuretics and other medications that effectively manage fluid buildup and improve patient outcomes in heart failure.
- Stroke and Systemic Embolism: Expertise in trials for stroke prevention medications, including blood thinners and antiplatelet drugs, as well as interventions to reduce blood clot formation.
- Coronary Heart Disease: A comprehensive approach to developing and testing medications for coronary artery disease prevention and management, including cholesterol-lowering drugs and therapies that improve blood flow to the heart.
- Acute Coronary Syndrome and Acute Myocardial Infarction: Proven experience in designing and conducting time-sensitive clinical trials for medications that improve outcomes in patients experiencing heart attacks and acute coronary events.
- Left Ventricular Hypertrophy: Expertise in researching and developing therapies that prevent or reverse heart muscle thickening, a major risk factor for heart failure.
- Ventricular Arrhythmias: A focus on clinical trials for medications and devices that effectively control irregular heartbeats and reduce the risk of sudden cardiac death.
- Aortic Stenosis: Experience in designing trials for medications and minimally invasive procedures to improve outcomes in patients with a narrowed aortic valve.
Our Services
We offer a comprehensive suite of services designed to support every aspect of cardiovascular research and clinical development. From designing and conducting clinical investigations to managing data, analyzing results, and ensuring regulatory compliance. Our services encompass site feasibilities, investigator selection, patient recruitment strategies, IRB submissions, GCP site audits, medical writing, biostatistics, SAS programming, device vigilance, safety reporting, and regulatory support.
By collaborating with Techsol, you gain access to tailored solutions designed to meet the unique challenges of your therapeutic area. From protocol design to regulatory compliance, our comprehensive services are tailored to support your trial at every stage.
We set ourselves apart in clinical research by going beyond just testing medications. We leverage our in-depth knowledge of cardiovascular diseases to design targeted trials, meticulously track patient progress, and contribute to the development of innovative treatment approaches for a broad spectrum of heart conditions. This patient-centric approach ensures we gather robust data to bring effective therapies to market faster.
Our Experience
|
S.No |
Product Details |
Techsol’s Contribution |
|||||
|
Clinical Operations |
Medical Writing |
Regulatory Affairs |
Statistical & Analysis |
Clinical Data Management |
PV |
||
|
1 |
Amiodarone |
|
✔ |
|
|
|
|
|
2 |
Amlodipine |
|
✔ |
|
|
|
|
|
3 |
Furosemide |
✔ |
✔ |
|
✔ |
✔ |
|
|
4 |
Apixaban |
|
✔ |
|
|
|
|
|
5 |
Ezetimibe ODT 10 mg |
|
✔ |
|
|
|
|
|
6 |
Telmisartan+ Hydrochlorothiazide |
|
✔ |
|
✔ |
✔ |
|
|
7 |
Telmisartan+ Amlodipine |
|
✔ |
|
|
|
|
|
8 |
Telmisartan + Amlodipine +Hydrochlorothiazide |
|
✔ |
|
✔ |
✔ |
✔ |
|
9 |
Ezetimibe and Atorvastatin |
|
✔ |
|
|
|
|
|
10 |
Lisinopril |
|
|
✔ |
|
|
|
|
11 |
Diltiazem |
|
|
✔ |
|
|
|
|
12 |
Clopidogrel |
|
✔ |
|
✔ |
✔ |
|
|
13 |
Losartan Potasium |
|
✔ |
|
✔ |
✔ |
|
|
14 |
Fenofibrate |
|
|
✔ |
|
|
✔ |
|
15 |
Trans catheter Aortic Valve System |
✔ |
|
|
|
|
|
|
16 |
Lidocaine |
|
|
✔ |
✔ |
✔ |
|
|
17 |
Nadolol |
|
|
✔ |
|
|
|